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Introduction: In 2006 the UK introduced legislation to allow appropriately trained
health care personnel to prescribe any medicine (except some controlled drugs)
for a condition within their competence, as part of a program to ease the burden
on hard pressed medical staff and enhance the role of other workers. In keeping
with this, specialist CF nurses in our unit undertook prescriber training: we were
interested in assessing their performance.
Method: We audited all outpatient prescriptions over a 7 month period (Feb–Aug
2007) from 2 CF Nurse Specialists who had undergone prescriber training.
Results: Of 115 prescriptions written by the CF Nurse Specialists, 71 (62%)
were for multiple drugs (up to 7). In every case, the prescription was appropriate
for the nurses’ patient group. Fifty six prescriptions (49%) were for intravenous
antibiotics, 19 (17%) for oral antibiotics, 27 (23%) for nebulised medications, 8
(7%) for nutritional or vitamin support, 3 (3%) for laxatives, 2 (2%) for anti-fungal
medications and 3 (3%) for pancreatic enzymes. The remaining scripts were for a
variety of drugs including oral steroids, analgesia, insulin and anti-histamines.
Conclusion: The changes in prescribing legislation in the UK has brought with it a
diversity of prescribing options, reﬂected in the variety of drugs seen in this audit.
CF Nurse Specialists are in an ideal position to utilize this change in legislation
due to the chronic nature of their patient population. Previously, these prescriptions
would have been the responsibility of medical staff: the changes have not only
increased nurses’ autonomy and professional status, but have made access to timely
and appropriate treatment easier for this patient group.
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People with chronic medical problems are at increased risk of psychological distress.
Research ﬁndings in the CF population are equivocal although it is suggested
that older patients may be vulnerable. The HADS measures severity of anxiety,
depression and severity of emotional disorder.
The aim of the study was to evaluate the value of HADS in identifying distressed
inpatients and to investigate any relationship with age. It was administered by a CF
specialist nurse.
44 patients took part in the study (23 male 21 female) with a mean age of 31 years
(range 18−57). In total 25 (49%) patients met the criteria for anxiety and 18 (35%)
met the criteria for depression (See table). There was no signiﬁcant correlation
between age and HADS anxiety or depression scores. 12 patients required no
intervention, 15 showed clinical signs but chose not to pursue treatment, 8 were
referred to psychiatry or psychology or commenced on medication. 9 were already
receiving emotional care and/or medication. Of 9 patients asked all felt the score
was a true reﬂection of their emotional state.
Results showed high levels of distress. These may have been inﬂated due to
the inpatient sample. In contrast with earlier ﬁndings there was no signiﬁcant
relationship between HADS score and age. As this relationship is likely to be
mediated by physical health status, future studies should include measures of disease
severity.
The role of the CF nurse is to provide holistic care and using the HADS was a
useful tool in facilitating sensitive discussions.
HADS score results
HADS score Anxiety Depression
Mild 14 (32%) 12 (27%)
Moderate 5 (11%) 5 (11%)
Severe 6 (14%) 1 (2%)
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Aim: Transplanted CF patients were screened for anxiety and depression as part of
a multi-centre study on psychological aspects of CF and transplantation (Tx).
Method: During 2006, all but two Belgian transplanted CF patients completed
the Hospital Anxiety and Depression Scale (HADS). Demographic data collected
included age, gender, relationship status, work/study status and living situation.
Medical data were time since Tx, lung function and the presence or absence of
chronic rejection. Scores were compared to reference scores obtained from a pre-
transplant CF patient cohort.
Results: 66 patients participated (37 females, 29 males). Mean age was 32 (st.dev.9)
and mean FEV1 was 84% (st.dev. 22). 48 patients (73%) showed no signs of chronic
rejection.
For anxiety, 14% of patients scored in the severe range, 24% in the medium
range and 62% in the normal range. For depression the results were 4%, 1% and
94% respectively. Anxiety mean scores were not different from reference scores;
depression mean scores were signiﬁcantly lower (2.17 vs 3.36 respectively, p< 0.05).
HADS scores were not related to the demographic variables, time since Tx or lung
function. Patients with signs of rejection scored higher on anxiety.
Conclusions: Of the transplanted CF patients in Belgium, 38% scored in the
medium or severe range for anxiety, which is similar to scores of a pre-Tx CF
group. Depression scores were signiﬁcantly lower in the Tx group. Anxiety was
higher in patients with chronic rejection. Tx and the continued risk of rejection
may enhance feelings of anxiety. CF patients should be screened for anxiety before
and after Tx as part of the programme and adequate coping strategies should be
promoted.
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Cystic ﬁbrosis is a complex multi-system disease. Patients often face a number
of physical and psychological problems. It is acknowledged that psychological
morbidity has adverse effects on the outcome of medical illnesses, and therefore
addressing the psychological needs is important. The UK National Consensus
Standards for the Nursing Management of Cystic Fibrosis states that patients should
be supported by specialist nurses who have knowledge and experience of cystic
ﬁbrosis, the disease process and the clinical and psychological outcomes.
80 patients attending the Adult Clinic were asked to complete the Hospital Anxiety
and Depression Questionnaire when attending Clinic, with an explanation regarding
the purpose of the assessment. Results were then collated. Scores between 8−10
indicate mild symptoms; 11−14 moderate symptoms; 15−21 severe symptoms.
80 CF patients (41 males; age range 18−57) completed questionnaires. 33 patients
(41%) reported signiﬁcant scores (>8) for either anxiety or depression. 26 patients
(33%) recorded clinically signiﬁcant scores for anxiety (17 mild; 6 moderate;
3 severe); 17 were female (65%). 7 (9%) reported clinically signiﬁcant scores
for depression (3 mild; 3 moderate; 1 severe); 5 were male (71%). Those with
depression also had high scores for anxiety; 4 were male (57%).
Anxiety was more prevalent than depression. Anxiety was more common in women.
These results indicate the need for the cystic ﬁbrosis team to develop treatment
strategies such as cognitive behavioural therapy for the management of anxiety and
depression.
